HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lixivaptan

structure in first source
Also Known As:
5-fluoro-2-methyl-N-(4-(5H-pyrrolo(2,1-c)-(1,4)benzodiazepin-10-(11H)-ylcarbonyl)-3-chlorophenyl)benzamide; N-4-(3-chloro-4-(5H-pyrrolo(2,1-C)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methylbenzamide; VPA 985; VPA-985; WAY VPA-985; WAY-VPA-985
Networked: 40 relevant articles (6 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Abraham, William T: 5 articles (12/2012 - 04/2006)
2. Ghali, Jalal K: 4 articles (05/2013 - 11/2010)
3. Orlandi, Cesare: 4 articles (12/2012 - 10/2010)
4. Decaux, Guy: 3 articles (02/2015 - 04/2003)
5. Zmily, Hammam D: 3 articles (05/2013 - 11/2010)
6. Rosner, Mitchell H: 2 articles (01/2013 - 12/2012)
7. Josiassen, Richard C: 2 articles (12/2012 - 12/2012)
8. Bichet, Daniel G: 2 articles (12/2012 - 12/2012)
9. Daifallah, Suleiman: 2 articles (06/2011 - 11/2010)
10. Soupart, Alain: 1 article (02/2015)

Related Diseases

1. Hyponatremia
2. Body Weight (Weight, Body)
3. Heart Failure
4. Ascites
5. Fibrosis (Cirrhosis)

Related Drugs and Biologics

1. tolvaptan
2. Sodium
3. conivaptan (Vaprisol)
4. satavaptan
5. Vasopressins (Vasopressin)
6. Vasopressin Receptors (Arginine Vasopressin Receptor)
7. Hormones
8. Diuretics
9. peptide V
10. Teriparatide (Parathar)